Agora’s Latest – “Agora Financial’s FDA Trader”
by Sarge | July 24, 2015 10:46 am
Agora[1] is claiming a ”flaw” in the stock market via the ”PDUFA” (an acronym that originated with the Prescription Drug User Fee Act) that allows them to know in advance a ”magic” date that the FDA[2] will reveal critical information about a certain drug’s approval or disapproval status. To quote Agora, ”during the review process of a new drug, the FDA will often “tip their hand” to certain investors — and reveal the exact day when the FDA plans to announce whether or not a drug has been approved…”. All you have to do is get your trade in before that date then await the windfall.
November 11, 2015 is the latest date being touted. Very tempted to give them my hard earned $1500 for a 12 month subscription but don’t want to get disappointed.
Anyone involved this that will admit to it? It’s TOP SECRET per Agora.
- Agora: https://www.stockgumshoe.com/tag/agora/
- FDA: https://www.stockgumshoe.com/tag/fda/
Source URL: https://www.stockgumshoe.com/2015/07/microblog-agoras-latest-agora-financials-fda-trader/
I’d like to know more about those “magic dates” too, especially since Nov. 11 is coming fast. However, just because the FDA is posting info regarding a new drug, it could just as easily announce that it needs more testing and is NOT approved. How can we tell beforehand if the drug is a winner or a loser? I’m not sure Agora actually makes that clear.